Telesta Therapeutics Inc. (BNC)

[BioSpecialist]

Great News from Endo on Monday 1 Nov 2010..

[B]The Fantastic News is around the corner .THIS SLEEPING GIANT WILL AWAKE VERY SOON .Remember there is NO Insider selling , NO Dilution even after 400% increase in Share price all this indicates that much much higher Share Price and good news is coming . Patience will pay off here big time![/B]

http://www.morningstar.com/earnings/PrintTranscript.aspx?id=18732547


[B]Asa final note, we plan to begin enrolling patients in the next study of Urocidin in refractory bladder cancer during the fourth quarter. This will serve as a registration trial comparing Urocidin to Mitomycin, the current standard treatment for this condition. Urocidin is a novel treatment for bladder cancer and reflects our commitment to this therapeutic area.

I am pleased with our clinical progress and look forward to resolving our marketing applications that are pending before the FDA.[/B]

Ivan Gergel, M.D. - EVP, Research & Development: Soon AVEED, as you know we met with FDA earlier this year. We are still considering the outcome of that meeting. We are still very muchcommitted to AVEED. We believe it has a significant place to play in theworld of testosterone replacement therapy. [B]The other one, the Urocidin study, the phase III study that was just completed. We are finalizing some of the data review, but we hopefully will be able to release date for that quite shortly – from that study quite shortly.[/B]